Barnabas et al recommend a public health COVID-19 vaccination strategy to maximize the health gains for every single vaccine dose At the forefront of innovations during the coronavirus disease 2019 (COVID-19) pandemic is the design and testing of the Pfizer-BioNTech and Moderna mRNA vaccines, both of which have extremely high efficacy in the prevention of COVID-19 after 2 doses given 21 to 28 days apart These vaccines were administered to thousands of people in placebo-controlled randomized trials The rollout to high-risk persons has begun in the UK, the US, and Canada The next critical step is population-wide delivery of COVID-19 vaccination to maximally reduce morbidity and mortality Barnabas et al propose that priority should be given to providing a single dose to as many people as possible, rather than emphasizing the 2-dose vaccination
A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose